Ebola Vaccine Trials Using Ring Vaccination
Gathering samples to test in the lab |
This summer I interned with the National Institute of Health (NIH). While there, I worked on research in the laboratory of virology under the director Heinz Feldmann, developer of the rVSV-EBOV Ebola vaccine that is currently in trials. A hot spot in the development of vaccines that has been pioneered by Dr. Feldmann is the use of recombinant Vesicular Stomatitis virus. Using this method, it is possible to combine the genetic material of Vesicular Stomatitis virus with parts of the Ebola virus genome that are not infectious. Vesicular Stomatitis virus is a virtually harmless virus that most humans have never been exposed to, but that we develop strong antibodies against. By infecting ourselves with this virus which is combined with some genetic material from the Ebola virus, our immune systems can recognize future infection with the Ebola virus. This new method of vaccine development is not only being used to gain immunity to Ebola virus, but also to Nipah, Marburg, Lassa, Crimean-Congo, and many other viral diseases.
To distribute such vaccines in times of outbreaks, public health workers have begun adopting the ring vaccination method. When a person is suspected to be infected with a disease such as Ebola, ring vaccination calls for every contact of that person to be vaccinated. by creating the vaccine "rings" around potential cases of disease in a timely manner, it is possible to slow and stop the spread of disease. In the current Ebola outbreak that is coming to a close in the Congo, this method paired with new vaccine development methods have been attributed the credit for saving hundreds if not thousands of lives.
To distribute such vaccines in times of outbreaks, public health workers have begun adopting the ring vaccination method. When a person is suspected to be infected with a disease such as Ebola, ring vaccination calls for every contact of that person to be vaccinated. by creating the vaccine "rings" around potential cases of disease in a timely manner, it is possible to slow and stop the spread of disease. In the current Ebola outbreak that is coming to a close in the Congo, this method paired with new vaccine development methods have been attributed the credit for saving hundreds if not thousands of lives.
This is super cool. I had no idea that was how the vaccine worked. I'm in an immunology class right now, so that is way interesting to me. I know there are some religious groups that refuse vaccines for moral reasons. Is that a potential threat to this approach? If so, how are health officials navigating that issue?
ReplyDelete